iBEST provides a collaborative platform for medical research, leading to new and innovative ways of helping patients. With its state-of-the-art labs and infrastructure, the institute is driving discoveries that align with market needs across four main research areas.
BIOMATERIALS, TISSUE INJURY & REPAIR (BTR)
Dr. Haibo Zhang is theme lead of BTR, leading a team of researchers from medical and engineering fields to collaborate on building an advanced scaffold for injured organs. The team is also working to identify key signaling pathways for crosstalk between exogenous and endogenous mesenchymal stromal cells (MSC) in order to accelerate cell regeneration in injured organs. In addition to cell therapy, the team will build and optimize non-invasive ventilator techniques to help lung regeneration after injury.
BIOMEDICAL DELIVERY SYSTEMS (BDS)
Dr. Scott Tsai is theme lead of BDS, heading a group of research teams that are striving to maximize the effectiveness of medication and minimize side effects through the application of microfluidics and nanotechnology. iBEST’s innovations in advanced drug delivery systems aim to improve the accuracy of therapeutic medicine and reduce healthcare costs.
BIOMEDICAL IMAGING & THERAPY (BIT)
Dr. General Leung is theme lead of BIT, steering research to develop technologies that enable imaging at the cellular and tissue levels for quick diagnosis, provide real-time feedback during surgery, and offer image guidance for radiation therapy to target and kill cancer cells without having to operate. The BIT teams are also using biomedical signal processing and mathematical modeling of physiological processes to better diagnose diseases, curb their progression, and develop new therapeutic options.
HEALTHCARE ANALYTICS & APPLICATIONS (HAA)
Dr. Alireza Sadeghian is theme lead of HAA, a team of researchers who are utilizing high-performance computing and data analytics tools to improve our understanding and ability to visualize the massive amounts of healthcare data available. This type of research has the potential to advance precision medicine, ultimately providing new insights into the field of healthcare, improving patient outcomes, and avoiding unnecessary costs.